ArticleThe Journal of clinical investigation2019

Oral ferroportin inhibitor ameliorates ineffective erythropoiesis in a model of β-thalassemia.

Vania Manolova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.